TABLE 2.
Comparison of the performances of PET and arterial- and venous-phase CT
| N = 14 | #1 | #2 | #3 | #4 | #5 | #6 | #7a | #7b | #8 | #9 | #10 | #11 | #12 | #13 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PET | + | + | + | + | + | + | + | + | + | + | + | + | + | + |
| CT, art. phase | - | c | c | c | c | + | c | c | + | - | c | c | + | - |
| CT, ven. phase | - | - | - | - | - | + | - | - | + | - | - | - | + | - |
| SUVmax | 23.4 | 43.6 | 5.9 | 43.7 | 31.5 | 6.2 | 9.0 | 5.5 | 64.6 | 9.5 | 10.3 | 11.3 | 58.0 | 14.1 |
| Localisation | ile | duo | ile | duo | duo | duo | jej | jej | duo | duo | jej | duo | ile | duo |
| Proceeding after PET/CT | OP | OP | FU 36m | FU 37m | OP | OP | OP | OP | OP | OP | FU 14m | OP | OP | FU 52m |
+ = suspicious lesion; - = nonsuspicious lesion; c = suspicious CT lesion in combination with PET (hyperperfusion) for true positive NET lesions (n = 14/13 patients) according to the reference standard; duo = duodenum; FU = follow-up; ile = ileum; jej = jejunum; m = months; OP = operation